跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,438 条关于
“Congenital adrenal hyperplasia”
全部
13,438
临床试验
12,573
药物
86
机构
19
资讯
760
去年
FDA Approves Neurocrine's Crenessity (crinecerfont) for Congenital Adrenal Hyperplasia
2年前
Crinecerfont Shows Promise in Treating Children with Congenital Adrenal Hyperplasia
9个月前
Crinetics Initiates Phase 3 Trial of Atumelnant for Congenital Adrenal Hyperplasia
去年
Crinecerfont Shows Promise in Pediatric Congenital Adrenal Hyperplasia Across All Patient Subgroups
去年
Lundbeck's Lu AG13909 Receives Orphan Drug Designation for Congenital Adrenal Hyperplasia Treatment
去年
FDA Grants Orphan Drug Designation to Crinetics' Atumelnant for Congenital Adrenal Hyperplasia Treatment
2年前
Phase 3 Trial of Crinecerfont Shows Promise in Treating Pediatric Congenital Adrenal Hyperplasia
去年
Crinetics' Atumelnant Shows Promise in Phase 2 Trial for Congenital Adrenal Hyperplasia
2年前
FDA Grants Breakthrough Therapy Designation to Crinecerfont for Congenital Adrenal Hyperplasia
去年
FDA Grants Priority Review to Crinecerfont for Congenital Adrenal Hyperplasia
第 1 页，共 76 页
上一页
下一页
